000 | 01627 a2200457 4500 | ||
---|---|---|---|
005 | 20250515035451.0 | ||
264 | 0 | _c20071206 | |
008 | 200712s 0 0 eng d | ||
022 | _a1552-4949 | ||
024 | 7 |
_a10.1002/cyto.b.20121 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBest, O G | |
245 | 0 | 0 |
_aZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis. _h[electronic resource] |
260 |
_bCytometry. Part B, Clinical cytometry _cJul 2006 |
||
300 |
_a235-41 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAntibodies _ximmunology |
650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
650 | 0 | 4 | _aAntigen-Antibody Reactions |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aFlow Cytometry _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin Variable Region _xgenetics |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdiagnosis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aStaining and Labeling |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aZAP-70 Protein-Tyrosine Kinase _xanalysis |
700 | 1 | _aIbbotson, R E | |
700 | 1 | _aParker, A E | |
700 | 1 | _aDavis, Z A | |
700 | 1 | _aOrchard, J A | |
700 | 1 | _aOscier, D G | |
773 | 0 |
_tCytometry. Part B, Clinical cytometry _gvol. 70 _gno. 4 _gp. 235-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cyto.b.20121 _zAvailable from publisher's website |
999 |
_c16493938 _d16493938 |